Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;29(1):109-22.
doi: 10.1016/j.idc.2014.11.009.

Fecal microbiota transplantation for the management of Clostridium difficile infection

Affiliations
Review

Fecal microbiota transplantation for the management of Clostridium difficile infection

Krishna Rao et al. Infect Dis Clin North Am. 2015 Mar.

Abstract

This article discusses the use of fecal microbiota transplantation (FMT) for the treatment of recurrent Clostridium difficile infection (CDI). The disruption of the normal gut microbiota is central to the pathogenesis of CDI, and disruption persists in recurrent disease. The use of FMT for recurrent CDI is characterized by a high response rate and short term safety is excellent, although the long-term effects of FMT are as yet unknown.

Keywords: Clostridium difficile; Colitis; Fecal microbiota transplantation; Microbiome; Nonantibiotic treatment; Recurrent C difficile infection.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Authors have no reported conflicts.

Figures

Fig. 1
Fig. 1
Pathogenesis of Clostridium difficile infection (CDI). This figure shows how a healthy gut microbiota (upper left corner) is altered by antibiotics to a susceptible state in which either asymptomatic colonization or symptomatic CDI can occur. Some patients do not have recovery of the microbiome back to a healthy state and experience recurrent CDI. Fecal microbiota transplantation can help restore the microbiome to a state resistant to CDI. (Adapted from Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 2014;146(6):1547–53; with permission.)
Fig. 2
Fig. 2
Diversity of the gut microbiome and recurrent Clostridium difficile infection. Rarefaction curve analysis indicates that patients with recurrent infection have lower diversity of their gut microbiome compared with healthy controls or patients with a successfully treated initial infection. (Adapted from Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile–associated diarrhea. J Infect Dis 2008;197(3):435–8; with permission.)
Fig. 3
Fig. 3
Composition of the gut microbiome after stool transplant. The microbial composition of the patient’s stool after transplant is similar to the donor’s stool and is more diverse than before transplant. (Adapted from Seekatz AM, Aas J, Gessert CE, et al. Recovery of the gut microbiome following fecal microbiota transplantation. mBio 2014;5(3):e00893–914; with permission.)

References

    1. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227. - PMC - PubMed
    1. Van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JE. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. Epidemiol Infect. 1971;69(03):405–411. - PMC - PubMed
    1. Vollaard E, Clasener H. Colonization resistance. Antimicrob Agents Chemother. 1994;38(3):409. - PMC - PubMed
    1. Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014;146(6):1547–1553. - PMC - PubMed
    1. Theriot CM, Koenigsknecht MJ, Carlson PE, Jr, et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 2014;5:3114. - PMC - PubMed

Publication types